Comparison
21q22 11q22 12 Microdeletion Syndrome C5192593 vs 14q24 1q24 3 Microdeletion Syndrome C4750911
Clinical comparison between 21q22 11q22 12 Microdeletion Syndrome and 14q24 1q24 3 Microdeletion Syndrome for differential diagnosis and treatment planning.
21q22 11q22 12 Microdeletion Syndrome C5192593
A rare genetic condition involving deletion of a specific region on chromosome 21. It may cause developmental delay, intellectual disability, and distinctive facial features. Management focuses on developmental support and medical monitoring.
14q24 1q24 3 Microdeletion Syndrome C4750911
A rare genetic deletion involving part of chromosome 14. It can affect development and lead to various medical issues. Management focuses on supportive care and addressing specific needs.
6 comparison axes
Onset
21q22 11q22 12 Microdeletion Syndrome C5192593
0-0
14q24 1q24 3 Microdeletion Syndrome C4750911
0-null
Onset patterns differ
Severity
21q22 11q22 12 Microdeletion Syndrome C5192593
severe
14q24 1q24 3 Microdeletion Syndrome C4750911
moderate
Different severity levels
Chronic
21q22 11q22 12 Microdeletion Syndrome C5192593
Chronic
14q24 1q24 3 Microdeletion Syndrome C4750911
Chronic
Differing course
Communicable
21q22 11q22 12 Microdeletion Syndrome C5192593
No
14q24 1q24 3 Microdeletion Syndrome C4750911
No
Different transmission
Body System
21q22 11q22 12 Microdeletion Syndrome C5192593
congenital
14q24 1q24 3 Microdeletion Syndrome C4750911
congenital
Same/different system
Category
21q22 11q22 12 Microdeletion Syndrome C5192593
rare-disease
14q24 1q24 3 Microdeletion Syndrome C4750911
genetic
Different category
Bottom line
21q22-11q22-12-microdeletion-syndrome-C5192593 and 14q24-1q24-3-microdeletion-syndrome-C4750911 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 21q22 11q22 12 Microdeletion Syndrome C5192593 | 14q24 1q24 3 Microdeletion Syndrome C4750911 | Discriminating power |
|---|---|---|---|
| Developmental delay | Described as possible, with intellectual disability. | Development may be affected; specifics are not established. | Low |
| Facial appearance | Distinctive facial features are mentioned. | No specific facial pattern is supplied. | Moderate |
| Overall clinical severity | Source severity is listed as severe. | Source severity is listed as moderate. | Moderate |
When to favor each condition
Choose 21q22 11q22 12 Microdeletion Syndrome C5192593 when
Confirmed deletion in the stated chromosome 21 region
The chromosomal locus, not symptoms alone, defines this concept.
High
Developmental delay with reported intellectual disability
This matches the sparse left description but is not specific.
Low
Need for developmental support and monitoring
Supportive management is explicitly described for the left concept.
Moderate
Choose 14q24 1q24 3 Microdeletion Syndrome C4750911 when
Confirmed deletion in the stated chromosome 14 region
Laboratory localization distinguishes it from a chromosome 21 deletion.
High
Developmental concerns without a defined syndrome pattern
The right description is broad and does not establish a specific phenotype.
Low
Individualized supportive-care planning
Management is described as addressing identified needs.
Moderate
How key tests differ
| Test | 21q22 11q22 12 Microdeletion Syndrome C5192593 | 14q24 1q24 3 Microdeletion Syndrome C4750911 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May detect the specified chromosome 21 deletion. | May detect the specified chromosome 14 deletion. | A deletion is a laboratory finding; clinical diagnosis requires expert correlation. |
| Karyotype | May miss a small deletion; result not predictable here. | May miss a small deletion; result not predictable here. | A normal karyotype does not exclude either microdeletion. |
| Developmental assessment | May document delay or intellectual disability. | May document developmental effects of unspecified type. | Assessment supports care needs but cannot identify the chromosome involved. |
Prognosis comparison
21q22 11q22 12 Microdeletion Syndrome C5192593
- Outcome
- Long-term outcome is not established; source severity is severe.
- Factors
- Developmental profile and associated medical findings may influence needs.
14q24 1q24 3 Microdeletion Syndrome C4750911
- Outcome
- Long-term outcome is not established; source severity is moderate.
- Factors
- The range and severity of developmental and medical issues may influence needs.
Time frame: Both are described as chronic and congenital, without a defined timeline.
Prognosis should be interpreted by clinicians using the confirmed deletion and individual evaluation.
Complications comparison
| Complication | Presentation |
|---|---|
| Learning or developmental difficulty | Intellectual disability is explicitly possible. Developmental effects are possible but unspecified. Severity and functional impact require individual assessment. |
| Additional medical issues | Not specifically established beyond the supplied features. Various medical issues are mentioned without detail. Do not infer organ-specific complications from these descriptions. |
| Long-term support needs | Monitoring and developmental support are emphasized. Supportive care and needs-based management are emphasized. Neither description establishes life expectancy or complication rates. |
Patient education highlights
- HighGenetic confirmation
The chromosome and deleted region must be confirmed by a qualified genetics service.
- HighIndividual variation
Features and severity can vary; these summaries do not predict one person’s course.
- MediumSupportive care
Care generally focuses on development, identified medical needs, and coordinated follow-up.